296 related articles for article (PubMed ID: 15748287)
1. Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?
Pickard AS; Wang Z; Walton SM; Lee TA
Health Qual Life Outcomes; 2005 Mar; 3():11. PubMed ID: 15748287
[TBL] [Abstract][Full Text] [Related]
2. A cost-utility analysis of chronic spinal pain treatment outcomes: converting SF-36 data into quality-adjusted life years.
Hatten AL; Gatchel RJ; Polatin PB; Stowell AW
Clin J Pain; 2006 Oct; 22(8):700-11. PubMed ID: 16988566
[TBL] [Abstract][Full Text] [Related]
3. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
4. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
5. When does quality-adjusting life-years matter in cost-effectiveness analysis?
Chapman RH; Berger M; Weinstein MC; Weeks JC; Goldie S; Neumann PJ
Health Econ; 2004 May; 13(5):429-36. PubMed ID: 15127423
[TBL] [Abstract][Full Text] [Related]
6. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
[TBL] [Abstract][Full Text] [Related]
7. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
8. A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index.
O'Brien BJ; Spath M; Blackhouse G; Severens JL; Dorian P; Brazier J
Health Econ; 2003 Nov; 12(11):975-81. PubMed ID: 14601159
[TBL] [Abstract][Full Text] [Related]
9. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.
Gupta OP; Brown GC; Brown MM
Am J Ophthalmol; 2008 May; 145(5):923-8. PubMed ID: 18329000
[TBL] [Abstract][Full Text] [Related]
10. Preference-based outcome measures in cost-utility analyses. A 20-year overview.
Greenberg D; Pliskin JS
Int J Technol Assess Health Care; 2002; 18(3):461-6. PubMed ID: 12391940
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of letrozole in the extended adjuvant treatment of women with early breast cancer.
El Ouagari K; Karnon J; Delea T; Talbot W; Brandman J
Breast Cancer Res Treat; 2007 Jan; 101(1):37-49. PubMed ID: 16821085
[TBL] [Abstract][Full Text] [Related]
13. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
[TBL] [Abstract][Full Text] [Related]
14. Global cost-effectiveness of cataract surgery.
Lansingh VC; Carter MJ; Martens M
Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
[TBL] [Abstract][Full Text] [Related]
15. Cost-utility analysis of cochlear implants in Korea using different measures of utility.
Lee HY; Park EC; Kim HJ; Choi JY; Kim HN
Acta Otolaryngol; 2006 Aug; 126(8):817-23. PubMed ID: 16846923
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
[TBL] [Abstract][Full Text] [Related]
17. Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer.
Zeliadt SB; Etzioni RD; Penson DF; Thompson IM; Ramsey SD
Am J Med; 2005 Aug; 118(8):850-7. PubMed ID: 16084177
[TBL] [Abstract][Full Text] [Related]
18. A cost-effectiveness and cost-utility study of lung transplantation.
Vasiliadis HM; Collet JP; Penrod JR; Ferraro P; Poirier C
J Heart Lung Transplant; 2005 Sep; 24(9):1275-83. PubMed ID: 16143245
[TBL] [Abstract][Full Text] [Related]
19. Total or partial knee replacement? Cost-utility analysis in patients with knee osteoarthritis based on a 2-year observational study.
Xie F; Lo NN; Tarride JE; O'Reilly D; Goeree R; Lee HP
Eur J Health Econ; 2010 Feb; 11(1):27-34. PubMed ID: 19430952
[TBL] [Abstract][Full Text] [Related]
20. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
Roe RH; Lass JH; Brown GC; Brown MM
Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
